BioLineRx Ltd. (BLRX) stock coverage initiated with “Buy” in note to investors by Rodman & Renshaw

BioLineRx Ltd. (NASDAQ: BLRX) shares rose on Monday February 13 on lower trade volume than normal after more analysts initiated coverage on the stock.

Meanwhile U.S. stock-market indexes opened higher on Monday, setting intraday all-time highs shortly after market open. The S&P 500 SPX, +0.35% opened up 6 points, or 0.2%, at 2,322.

The Nasdaq Composite COMP, +0.44% began the session up 18 points, or 0.3% higher at 5,752. The Dow Jones Industrial Average DJIA, +0.51% added 64 points or 0.3%, to 20,340 at the open.

Analysts at Rodman & Renshaw initiated coverage on BioLineRx Ltd. (NASDAQ: BLRX) stock, rating the company at Buy. With a rating of Buy on the shares, the company has a 52-week high of $1.42. The one-year price target of $2.00 is higher than the opening price of $1.15, causing a fair amount of other analysts to report on the company in recent days. Price changes targets are not unheard of as analysts and brokerage firms will re periodic updates after beginning or initiating coverage.

Yesterday BioLineRx Ltd. (NASDAQ: BLRX) shares last traded at $1.16, an increase of $0.07 compared to the previous closing price. Opening at $1.15, they varied from $1.13 and $1.17 throughout the day.

BioLineRx Ltd. (NASDAQ: BLRX) now has a market cap of 65.46M.

BioLineRx Ltd. (NASDAQ: BLRX) Average Daily Trading Volume

162,759 shares crossed the trading desk yesterday, 30 percent below normal, out of a total float 44,504,000. lower than normal. Look for trading volume to pick up in the coming days as swing traders often use upticks in trading volume to identify heavy volume accumulation or distribution by institutional investors.

However, a single day of heavy buy side trading is not enough to assert a trend. As such, market traders will continue to watch for institutional sponsorship as a signal that financial institutions are moving forward.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Institutional investors such as these retain teams of analysts that investigate thousands of stocks. Thus, watching their interests is a good way to ensure you are buying the right stocks.

BioLineRx Ltd. (NASDAQ: BLRX) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By identifying trends, moving averages allow investors to make those trends work in their favor and increase the number of winning trades.

Trades for BioLineRx Ltd. (NASDAQ: BLRX) have ranged from $0.71 – 1.42, and the stock now has a 50-day MA of $0.97 and 200-day MA of $0.98. Today’s last price is 18.31%% under the 52 week high of $1.42.

Indeed, earnings growth is among the most crucial things to look at in regards to stock investing and, accordingly, investors seek companies that have grown their earnings by at least 25% for 3 consecutive years.

DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *